tradingkey.logo
tradingkey.logo
Pesquisar

Vivos Therapeutics Inc

VVOS
Adicionar à lista de desejos
0.453USD
-0.045-9.05%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
4.21MValor de mercado
PerdaP/L TTM

Mais detalhes de Vivos Therapeutics Inc Empresa

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.

Informações de Vivos Therapeutics Inc

Código da empresaVVOS
Nome da EmpresaVivos Therapeutics Inc
Data de listagemDec 11, 2020
CEOHuntsman (R. Kirk)
Número de funcionários109
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 11
Endereço7921 Southpark Plaza,
CidadeLITTLETON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal80120
Telefone18669084867
Sitehttps://vivos.com/
Código da empresaVVOS
Data de listagemDec 11, 2020
CEOHuntsman (R. Kirk)

Executivos da empresa Vivos Therapeutics Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--
Dr. Matthew Thompson, M.D.
Dr. Matthew Thompson, M.D.
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Bradford K. (Brad) Amman
Mr. Bradford K. (Brad) Amman
Chief Financial Officer
Chief Financial Officer
80.00
--
Mr. R. Kirk Huntsman
Mr. R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Ralph E. Green, DDS
Dr. Ralph E. Green, DDS
Independent Director
Independent Director
--
--
Ms. Anja B. Krammer
Ms. Anja B. Krammer
Independent Director
Independent Director
--
--
Mr. Mark F. Lindsay
Mr. Mark F. Lindsay
Independent Director
Independent Director
--
--
Mr. Leonard J. (Lenny) Sokolow, CPA
Mr. Leonard J. (Lenny) Sokolow, CPA
Independent Director
Independent Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Vivos Therapeutics Inc?

Os cinco principais acionistas de Vivos Therapeutics Inc são: Mr. Bradford K. (Brad) Amman

Quantas instituições possuem ações da Vivos Therapeutics Inc (VVOS)?

Em 2026Q1, 50 instituições possuíam ações da Vivos Therapeutics Inc, com valor de mercado aproximado de 1.10M, representando 8.12% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -71775.00.

Qual é a maior fonte de receita da Vivos Therapeutics Inc?

Em 2026Q1, o segmento de negócios Sleep testing services gerou a maior receita para Vivos Therapeutics Inc, totalizando 2.56M e representando 37.74% da receita total.